-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2019%20CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
January 01, 2019 - consumer end users,” while more general references may use the
term “patient” as is commonly used in literature
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdf
January 01, 2024 - The SME clarified that based on USPSTF review of research literature the
correct way to express the
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2024 - manufacturers of statin medications remove the
contraindication to their use in all pregnant patients.8 Recent literature
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_CDS_Connect_IG_Diabetes_Part_One_Screening_0.pdf
January 01, 2024 - The SME clarified that
based on USPSTF review of research literature the correct way to express the
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Implementation_Guide_Pain_Management_Summary_1.pdf
September 01, 2022 - In the 2021 update, three robust literature reviews commissioned by AHRQ covering opioid
medication
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2023_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2023 - manufacturers of statin medications remove the
contraindication to their use in all pregnant patients.8 Recent literature
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/Implementation%20Guide_Abnormal%20Blood%20Glucose%20and%20Type%202%20DM_Part%20One,%20Screening_Final.pdf
September 01, 2019 - The SME clarified that based on USPSTF review of research
literature the correct way to express the
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/Implementation%20Guide_Abnormal%20Blood%20Glucose%20and%20Type%202%20DM_Part%20Two%20Counseling_Final.pdf
September 01, 2019 - The SME clarified
that based on USPSTF review of research literature the correct way to express the
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Implementation_Guide_Pain_Management_Summary.pdf
September 01, 2021 - In the 2021 update 3 robust literature reviews commissioned by AHRQ covering opioid
medication for chronic
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
January 01, 2024 - of statin medications remove the
contraindication to their use in all pregnant patients.13 Recent literature
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/Implementation%20Guide%20Abnormal%20Blood%20Glucose%20and%20Type%202%20DM%20Counseling.pdf
September 01, 2021 - The SME clarified
that based on USPSTF review of research literature the correct way to express the
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/IG%20Abnormal%20Blood%20Glucose%20Type%202%20DM%20Screening.pdf
September 01, 2021 - The SME clarified that based on USPSTF review of research
literature the correct way to express the
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/508_2022_CDS_Connect_IG_T2DM_Part_One_Screening_final.pdf
January 01, 2022 - The SME clarified that
based on USPSTF review of research literature the correct way to express the
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/Implementation_Guide_Prediabetes_and_Type_2_Diabetes_Part_One_Screening.pdf
September 01, 2022 - The SME clarified that
based on USPSTF review of research literature the correct way to express the
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2023_CDS_Connect_IG_T2DM_Part_One_Screening_1.pdf
January 01, 2023 - The SME clarified that
based on USPSTF review of research literature the correct way to express the
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/2023_CDS_Connect_IG_T2DM_Part_Two_Counseling_0.pdf
January 01, 2023 - The SME clarified that based on USPSTF review of research literature the
correct way to express the
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
January 01, 2023 - statin medications remove the
contraindication to their use in all pregnant patients.
1
12 Recent literature